Criteria | HCV infected patients | Non-HCV patients | P value |
---|---|---|---|
Age | 57.6±8.59 | 57.9±9.45 | NS |
Minimum = 36 | Minimum = 42 | ||
Maximum = 79 | Maximum = 80 | ||
Sex | |||
- Male | 43 (86%) | 42 (84%) | NS |
- Female | 7 (14%) | 8 (16%) | |
Histopathological type | |||
- TCC | 32 (64%) | 19 (38%) | p= 0.009 |
- SCC | 18 (36%) | 31 (62%) | |
Tumour grade | |||
- Grade I | 10 (20%) | 26 (52%) | p= 0.000 |
- Grade II | 19 (38%) | 19 (38%) | |
- Grade III | 21 (42%) | 5 (10%) | |
Lymph Nodes (LNs) | |||
- Negative LNs | 38 (76%) | 40 (80%) | NS |
- Positive LNs | 12 (24 %) | 10 (20%) | |
Tumour staging | |||
- Stage (Ta) | 1 (2%) | 5 (10%) | p= 0.002 |
- Stage (T1) | 12 (24%) | 17 (34%) | |
- Stage (T2) | 13 (26%) | 15 (30%) | |
- Stage (T3) | 12 (24%) | 8 (16%) | |
- Stage (T4) | 12 (24%) | 5 (10%) | |
Metastases | |||
- Negative | 43 (86%) | 42 (84%) | NS |
- Positive | 7 (14%) | 8 (16%) |